Chapter 9 Nutrition and Blood

Size: px
Start display at page:

Download "Chapter 9 Nutrition and Blood"

Transcription

1 Chapter 9 page number 1 Chapter 9 Nutrition and Blood First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary and secondary care Specialist initiated drugs Secondary care, authorised independent prescribers or GPs with special interest initiation. Suitable for continuation by primary care. Shared care agreements may be applicable.. Secondary care only drugs Drugs only suitable for secondary care use and initiated by appropriate team or specialist. Primary care prescribers should not be asked to prescribe. Drug Form & Strength Notes 9.1 Anaemias and some other blood disorders Iron-deficiency anaemias see Acute Trust Guidance Oral iron Ferrous fumarate (first line for PCT) Tablets: 210mg Contains 68mg iron. Recommended doses: Treatment: 1 tablet TDS Prevention : 1 tablet OD Ferrous fumarate Capsules: 305mg Contains 100mg iron. Recommended doses: Treatment: 1 capsule BD Prevention: 1 capsule OD Ferrous sulfate (first line for GWH) Tablets: 200mg Contains 65mg iron. Recommended doses: Treatment: 1 tablet TDS Prevention : 1 tablet OD Ferrous fumarate Syrup (Galfer ): 140mg / 5 ml Contains 45mg iron/5ml. Sodium feredetate SF Elixir : 190mg / 5ml Contains 27.5mg iron/5ml. Ferrous fumarate + folic acid Ferric Maltol (Ferracru) Tablets: 305mg / 350microgram Capsules: 30mg Used for prophylaxis during pregnancy in women who are at high risk of developing iron and folic acid deficiency ONLY for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease and ONLY on the advice of a Consultant Gastroenterologist. Please note all supplies MUST be obtained via hospital outpatient prescription, as GPs will not be able to follow on prescribe Parenteral iron Please see MHRA Drug Safety Update (August 2013) for recommendations to manage and minimise the risk of serious hypersensitivity reactions.

2 Chapter 9 page number 2 Iron dextran (Cosmofer ) Iron sucrose (Venofer ) Ferric carboxymaltose (Ferinject ) For use only on the Renal Unit at GWH For use by Cherwell Unit/Aldbourne Ward ONLY for patients attending an IV iron clinic prior to hip or knee surgery. For use by Coate Water Unit ONLY for day patients with inflammatory bowel disease attending for IV iron infusion. Please note Ferinject is considerably more expensive than Cosmofer. In all other settings, Ferrinject may ONLY be used in patients with asthma, eczema or other atopic allergic conditions for whom cosmofer would be contraindicated Drugs used in megaloblastic anaemias Hydroxocobalamin Injection: 1mg / ml Folic Acid Tablets: 5mg, 400micrograms SF Oral solution: 2.5mg / 5ml Drugs used in hypoplastic, haemolytic, and renal anaemias Darbepoetin alfa Prefilled syringe: all strengths SureClick injection device: all strengths Epoetin alfa (Eprex) Desferrioxamine mesilate For use in renal patients only. Injection: 500mg vial Deferiprone Tablets: 500mg Drugs used in platelet disorders Anagrelide Capsules: 500micrograms Romiplostim Injection: To be used in accordance with NICE TA221. Same-day, PCT prior approval is required before romiplostim may be prescribed Eltrombopag Tablets: To be used in accordance with NICE TA Drugs used in neutropenia Filgrastim Accofil 30 million units in 0.5ml prefilled syringes. Accofil 48 million units in 0.5ml prefilled syringes. For use in post- chemotherapy neutropenia and stem cell mobilisation. Please see MHRA Drug Safety Update (September 2013) 9.2 Fluids and electrolytes Oral preparations for fluid and electrolyte imbalance Oral potassium Potassium chloride Sando-K Effervescent Tablets: 12mmol K + Kay-Cee-L SF Syrup: 1mmol K + / ml Potassium chloride Slow-K MR Tablets: 600mg 8mmol K + Potassium removal

3 Chapter 9 page number 3 Calcium polystyrene sulphonate Resonium A and Calcium Resonium Powder Oral sodium and water Sodium chloride MR Tablets: 600mg Sodium chloride Oral solution: 30% For consultant prescribing only. Oral rehydration therapy (ORT) Oral Rehydration Salts Oral powder (Dioralyte, Electrolade ) Oral bicarbonate Sodium bicarbonate Tablets: 600mg Paediatric oral solution: unlicensed. For paediatric consultant prescribing only.

4 Chapter 9 page number Parenteral preparations for fluid and electrolyte imbalance Electrolytes and water Refer to the following information: British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients. NPSA Alert Reducing the risk of hyponatraemia when administering IV infusions to children. Sodium Chloride Glucose Potassium Chloride Sodium Bicarbonate Sodium Chloride 0.45% with Glucose 5% Plasma and plasma substitutes Please see memo for information on availability of plasma expanders at GWH. Albumin solution Dextran 70 6 % in sodium chloride 0.9% Intravenous Infusion 500 ml Bag Gelofusine For endoscopy use only Plasmalyte 9.3 Intravenous nutrition Should only be prescribed by the Nutrition Team (Tel: ) and ICU clinicians. 9.4 Oral nutrition Prescribers are reminded that the Advisory Committee on Borderline Substances recommends products on the basis that they may be regarded as drugs for the treatment of specified conditions. Doctors should satisfy themselves that the products can be safely prescribed, that patients are adequately monitored and that, where necessary, expert hospital supervision is available. Prescriptions for products recommended by the Committee should be endorsed "ACBS" Foods for special diets Refer to BNF, appendix Enteral nutrition See 3Ts Guidelines on community MUST screening, Food First and use of oral nutrtional supplements. When introducing enteral nutrition to patients for the first time, prescribe a small number of assorted flavours or a starter pack as an acute prescription. It is always advisable to screen a patient to assess their requirements using the MUST tool. Please refer to following link If a patient does not find any formulary option palatable, please refer him/her to the GWH Dietetic Team ( ). For further information, see NICE CG32 Nutrition Support in Adults Probiotics Labinic Paediatric drops ONLY for use in neonates on Special Care Baby Unit.

5 Chapter 9 page number Minerals Calcium and magnesium Calcium supplements See section for combined calcium and vitamin D 3 preparations Adcal Chewable Tablets: 15mmol/tablet. Calcium Sandoz Sandocal-1000 Paediatric Syrup: 2.7mmol/5ml. Paediatric Tablets: 25mmol/tab. Calcium Gluconate Injection 10% Calcium Chloride Injection Hypercalcaemia and hypercalciuria Cinacalcet Tablets: 30mg, 60mg, 90mg For initiation by a Renal Specialist for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on dialysis, in line with NICE TA117. Cinacalcet Tablets: 30mg, 60mg, 90mg For initiation and follow-on prescribing by an Endocrinology Specialist for the treatment of complex primary hyperparathyroidism. Etelcalcetide For initiation and follow-on prescribing by a Renal Specialist for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease on haemodialysis, in line with NICE TA Magnesium See: UKMI Guidance on Treatment of Acute Hypomagnesaemia in adults Magnesium aspartate (Magnaspartate ) Sachet: 6.5g (10mmol Mg2+ per sachet). Licensed for the treatment and prevention of magnesium deficiency, where clinically indicated, in adults, adolescents and children aged 2 years and older. This is prescribable on FP10. Magnesium glycerophosphate (Neomag ) Chewable tablets: 97mg (4mmol Mg2+ per tablet). Licensed for the treatment of chronic magnesium loss or hypomagnesaemia, where clinically indicated, in adults, adolescents and children aged 4 years and older. Also licensed for adult patients with hypomagnesaemia due to the concomitant administration of loop and thiazide diuretics or other drugs which cause hypomagnesaemia. This IS prescribeable on FP10. Magnesium sulphate Injection: 50% - 2ml, 10ml, 20ml Phosphorus Phospate supplements

6 Chapter 9 page number 6 Phosphate-Sandoz Effervescent Tablets: 500mg Phosphates Polyfusor : 500ml Neo-nate50mg/1ml mixture (unlicensed special) Phosphate-binding agents Calcium acetate Tablets: 1g Sevelamer Tablets: 800mg Fluoride Sodium fluoride ONLY for initiation and follow-on prescribing by specialist, community or high-street dentists, unless the patient is resident in a care home, when their GP may prescribe it Zinc Zinc sulfate 9.6 Vitamins Vitamin A Vitamin A + D Toothpaste: 0.619% and 1.1%. Mouthwash: 0.05% and 2%. Effervescent Tablets: 125mg Capsules: 220mg Capsules: 4000 / 400 units

7 Chapter 9 page number Vitamin B Thiamine Tablets: 50mg, 100mg Pyridoxine hydrochloride Tablets: 10mg, 20mg, 50mg Vitamin B Compound Strong Tablets Nicotinamide Capsules: 50mg, 500mg For Dermatology only. Unlicensed preparation. Yellow script only. Pabrinex I/V High potency injection Vitamin C (Ascorbic acid) Ascorbic acid Tablets: 50mg, 100mg Vitamin D See also: 3Ts Chapter 10 Musculoskeletal. DEXA and osteoporosis guidelines. The main aim of osteoporosis management is to prevent fractures. Prevention is most appropriately targeted at those at high risk of osteoporosis. While there is no evidence that population-based prevention strategies reduce fractures, stopping smoking, taking weight-bearing exercise, ensuring adequate dietary calcium intake and preventing falls may be beneficial. Patients at high risk of osteoporosis include: postmenopausal women premature menopause (< 45 years) previous fragility fracture small, thin women premenopausal amenorrhoea long-term steroid use (> 7.5mg oral prednisolone daily for 6 months) family history of osteoporosis smokers Either HRT or bisphosphonates + calcium and vitamin D3 may be used for the treatment and prevention of osteoporosis. The choice of therapy depends on acceptability, tolerability and the presence of other possible indications for HRT. Adcal D3 or Calceos chewable tablets Tablets: 500mg (Calceos ) or 600mg (Adcal D3 )of calcium per tablet. For daily requirements see osteoporosis guidelines. Prescribers should prescribe whichever product is more cost-effective in their care setting. Adcal D3 contains soya oil & gelatin. Calceos contains partially hydrogenated soybean oil & gelatin. Adcal D3 caplets Calfovit D3 Alfacalcidol Calcitriol Caplets: 300mg of calcium per tablet. Powder: 1.2g/ 20 micrograms. Capsules: 250nanograms, 500nanograms, 1microgram. Oral drops: 2micrograms/ml. Capsules: 250nanograms, 500nanograms. For patients who cannot chew the conventional preparations For pts unable to take chewable tablets or caplets. 1 drop contains approximately 100nanograms. See NPSA Statement (Sept 2011)

8 Chapter 9 page number 8 Colecalciferol 20,000unit capsules (Fultium D3 ) See 3Ts Prescribing Guidance on Vitamin D deficiency and insufficiency in adults for further details. Licensed for use in children years old and adults. Please note capsules contain gelatin. Colecalciferol 3200 unit capsules ( Fultium D3 ) See 3Ts Prescribing Guidance on Vitamin D deficiency and insufficiency in adults for further details. Licensed for use in adults. Please note capsules contain gelatin. Colecalciferol 800 unit capsules ( Fultium D3 ) Colecalciferol oral solution 25,000 units/ml ( Invita D3 ) See 3Ts Prescribing Guidance on Vitamin D deficiency and insufficiency in adults for further details. See 3Ts Prescribing Guidance on Vitamin D deficiency and insufficiency in adults for further details. Licensed for use in children years old and adults. Please note capsules contain gelatin. Licensed for use in children 0-18 years old and adults. May be mixed with a small amount of cold or lukewarm food immediately before administration Vitamin E (Tocopherols) Alpha tocopheryl Tablets: 100mg Available on a named patient acetate basis only Vitamin K Phytomenadione solution Menadiol sodium phosphate Phytomenadione injection Tablets: 10mg Paediatric IV/oral/IM: 2mg in 0.2ml Tablets: 10mg Injection: 100mg in 1ml Konakion MM Paediatric (for im/iv/oral use). Licensed for the prophylaxis and treatment of haemorrhagic disease of the newborn. Water soluble preferable in malabsorption states and cholestasis. In the absence of menadiol 10mg tablets, phytomenadione (vitamin K injection 10mg/ml) may be used orally. This is an unlicensed use Multivitamin preparations Multivitamin +/- mineral preparations are not required if the patient is taking a balanced diet. If a patient s diet is not nutritiously complete, consult the MUST tool for further advice at

9 Chapter 9 page number 9 Abidec Oral drops Contains less vitamin A than Dalivit. For neo-nates prescribe as per SCBU guidelines. Substitute with Dalivit if Abidec unavailable Dalivit dose should not exceed 0.3ml in neo-nates. Dalivit Oral drops Used for cystic fibrosis patients and adults. Abidec is not suitable for anyone > 12years. Forceval Capsules Junior Capsules Ketovite Multivitamin Tablets Tablets SF Liquid Secondary Care Use Only 9.8 Metabolic disorders Drugs used in metabolic disorders Dependant on metabolic disorder presented. Penicillamine See 3Ts Chapter 10, section Carnitine Oral Liquid: 100mg / ml (10 x 10ml single dose) Paediatric solution: 300mg / ml Mercaptamine Capsules: 50mg, 150mg Sodium phenylbutyrate Tablets: 500mg Biotin Tablets: 5mg Injection: 5mg/ml Arginine Tablets: 500mg Oral solution: 50mg/ml Powder: 100g Injection: 500mg/ml Sodium benzoate Tablets: 500mg Capsules: 50mg, 250mg, 400mg, 500mg Oral solution: 100mg/ml, 200mg/ml, 300mg/ml Injection: 200mg/ml For paediatric consultant prescribing only Acute porphyrias Acute porphyrias Haem arginate Concentrate for IV infusion: 25mg / ml Miscellaneous Baby Milk Formulas See formulary guidelines. NHS Swindon, NHS Wiltshire and Great Western Hospitals NHS Foundation Trust in collaboration with Avon & Wilts Mental Healthcare Partnership Trust.

Chapter 9 Nutrition and Blood

Chapter 9 Nutrition and Blood Chapter 9 page number 1 Chapter 9 Nutrition and Blood First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary

More information

BNF 9: Blood and Nutrition

BNF 9: Blood and Nutrition FORMULARY CHOICE RESTRICTED 1 Blood and Blood-Forming Organs 1.1 Anaemias Epoetins Epoetinalfa pre-filled (Eprex ) 1,000unit 2,000unit 3,000unit 4,000unit 5,000unit 6,000unit 8,000unit 10,000unit 20,000unit

More information

Report generated from MPH Formulary provided by FormularyComplete ( Accessed Formulary Status. TA Number.

Report generated from MPH Formulary provided by FormularyComplete (  Accessed Formulary Status. TA Number. Report generated from MPH provided by Complete (www.pharmpress.com). Accessed 18 01 2016 Title Status Section TA Number TA Link Colecalciferol No UK PL 9.6 Vitamins->9.6.4 Vitamin D->COLECALCIFEROL Colecalciferol

More information

Report generated from BNF provided by FormularyComplete ( Accessed TA Number. Title Formulary Status Section

Report generated from BNF provided by FormularyComplete (  Accessed TA Number. Title Formulary Status Section Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation Abidec Adcal-D3 Addiphos Additrace 9.6 Vitamins->9.6.7

More information

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Contents: Blood disorders 1 1. Anaemia 2 A. Non-renal patients 2 B. Patients with chronic kidney disease under the care of

More information

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Contents: Blood disorders 1 1. Anaemia 2 A. Non-renal patients 2 B. Patients with chronic kidney disease under the care of

More information

9: Nutrition and blood

9: Nutrition and blood Original date of issue: 30/01/2006 Last Reviewed: 17/09/2011 Version:4 Page 1 of 18 9: Nutrition and blood 9.1 Anaemias and some other blood disorders 9.1.1 Iron-deficiency anaemias 9.1.1.1 Oral iron Iron

More information

Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3

Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3 Medicines Formulary Nutrition, blood and electrolyte disorders Contents: Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3 Blood disorders 3 4. Anaemia 3 A.

More information

BNF CHAPTER 9: NUTRITION & BLOOD

BNF CHAPTER 9: NUTRITION & BLOOD 9.1 ANAEMIAS BNF CHAPTER 9: NUTRITION & BLOOD 9.1.1 IRON-DEFICIENCY ANAEMIAS 9.1.1.1 ORAL IRON Use of modified release iron preparations is not recommended since these preparations release iron beyond

More information

9. Nutrition and blood

9. Nutrition and blood 9. Nutrition and blood 1 9.1 - Anaemia and some other blood disorders 9.1.1 Iron deficiency anaemias 9.1.1.1 Oral Iron Ferrous fumarate Ferrous sulfate Sodium feredetate (Sytron ) Haemoglobin should rise

More information

VITAMIN D DEFICIENCY IN CHILDREN AND ADULTS: TREATMENT AND PROPHYLAXIS GUIDELINE

VITAMIN D DEFICIENCY IN CHILDREN AND ADULTS: TREATMENT AND PROPHYLAXIS GUIDELINE VITAMIN D DEFICIENCY IN CHILDREN AND ADULTS: TREATMENT AND PROPHYLAXIS GUIDELINE SECTION A. DEFINITION AND DIAGNOSIS The main source of vitamin D is from the action of UVB sunlight on the skin, which results

More information

First line drugs Second line drugs Specialist drugs Hospital only drugs

First line drugs Second line drugs Specialist drugs Hospital only drugs CHAPTER 9 NUTRITION AND BLOOD First line drugs drugs recommended in both primary and secondary care Second line drugs alternatives (often in specific conditions) in both primary and secondary care Specialist

More information

Northern Treatment Advisory Group

Northern Treatment Advisory Group Northern Treatment Advisory Group Ferric Maltol (Feraccru ) for the treatment of iron deficiency Lead author: Daniel Hill Regional Drug & Therapeutics Centre (Newcastle) September 2018 2018 Summary Iron

More information

1. Adults; a. Risk factors. b. Who should be tested for vitamin D deficiency? c. Investigations. d. Who do we treat and how do we treat? 2.

1. Adults; a. Risk factors. b. Who should be tested for vitamin D deficiency? c. Investigations. d. Who do we treat and how do we treat? 2. Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management For Adults and Children Adapted from existing local guidance, National Osteoporosis Society Practical Guides and from Royal

More information

378FM.2 VITAMIN SUPPLEMENTATION FOR PAEDIATRIC CYSTIC FIBROSIS (CF) PATIENTS

378FM.2 VITAMIN SUPPLEMENTATION FOR PAEDIATRIC CYSTIC FIBROSIS (CF) PATIENTS 378FM.2 VITAMIN SUPPLEMENTATION FOR PAEDIATRIC CYSTIC FIBROSIS (CF) PATIENTS Oxford University Hospitals and the Royal Brompton are the tertiary CF centres serving Buckinghamshire. Many patients are under

More information

GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006)

GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006) When commencing re-feeding: NICE (2006) NICE (2006) Clinical Guideline 32 Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition (The following is based on www.nice.org.uk/cg032

More information

codex alimentarius commission

codex alimentarius commission codex alimentarius commission FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS WORLD HEALTH ORGANIZATION JOINT OFFICE: Viale delle Terme di Caracalla 00100 ROME Tel.: 39.06.57051 Telex: 625825-625853

More information

Seven Easy Steps To Assess Non-Compliance Of A Food Supplement

Seven Easy Steps To Assess Non-Compliance Of A Food Supplement Seven Easy Steps To Assess Non-Compliance Of A Food Supplement Three easy immediate checks of the label 1. If a product is labelled as Dietary Supplement, it is non-compliant. All food supplements must

More information

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT Phosphate Binders for the Treatment of Hyperphosphataemia in adults with Chronic Kidney Disease OBJECTIVES To outline referral

More information

VITAMIND. Frequently asked questions about Vitamin D in childhood

VITAMIND. Frequently asked questions about Vitamin D in childhood VITAMIND Frequently asked questions about Vitamin D in childhood Introduction Around the UK there are different recommendations for the prevention, detection and treatment of Vitamin D deficiency. The

More information

CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY& INSUFFICIENCY IN ADULTS

CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY& INSUFFICIENCY IN ADULTS CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY& INSUFFICIENCY IN ADULTS INTRODUCTION Vitamin D is essential for skeletal growth and bone health. Dietary sources in the UK are very

More information

Food for special medical purposes. phenylketonuria (PKU) Important notice: Suitable only for individuals with proven phenylketonuria.

Food for special medical purposes. phenylketonuria (PKU) Important notice: Suitable only for individuals with proven phenylketonuria. PKU Nutri 1 Energy Food for special medical purposes. For the dietary management of proven phenylketonuria (PKU) in infants from birth to 12 months and as a supplementary feed up to 3 years. An amino acid

More information

***II POSITION OF THE EUROPEAN PARLIAMENT

***II POSITION OF THE EUROPEAN PARLIAMENT EUROPEAN PARLIAMENT 1999 2004 Consolidated legislative document 13 March 2002 2000/0080(COD) PE2 ***II POSITION OF THE EUROPEAN PARLIAMENT adopted at second reading on 13 March 2002 with a view to the

More information

Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease

Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease Information for patients The following pages offer you information on some of the medicines that you may need. It is

More information

Medibios Laboratories Private Limited, India Nutraceutical / OTC & Cosmetics product List Product Description

Medibios Laboratories Private Limited, India Nutraceutical / OTC & Cosmetics product List Product Description Sr. No. Medibios Laboratories Private Limited, India Product Description 1 Calcium with Vitamin D3 and Mineral Tablets Each film-coated tablet contains: Calcium Carbonate BP equivalent to Elemental Calcium

More information

Clinical Guideline Bone chemistry management in adult renal patients on dialysis

Clinical Guideline Bone chemistry management in adult renal patients on dialysis Clinical Guideline Bone chemistry management in adult renal patients on dialysis This guidance covers how to: Maintain serum phosphate 0.8 to 1.7mmol/L 1 Maintain serum corrected calcium 2.1 to 2.5mmol/L

More information

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults. Consultation Group: See Page 4. Review Date: June 2021

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults. Consultation Group: See Page 4. Review Date: June 2021 NHS...... Grampian NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults Co-ordinators: Consultation Group: Approver:. Senior Medicines Information Pharmacist See Page 4 Medicine

More information

Initial Pathway for DEXA Referral and Treatment for Fracture Risk Reduction in Postmenopausal Women and Men Age 50 or Above

Initial Pathway for DEXA Referral and Treatment for Fracture Risk Reduction in Postmenopausal Women and Men Age 50 or Above Initial Pathway for DEXA Referral and Treatment for Fracture Risk Reduction in Postmenopausal Women and Men Age 50 or Above 2 or > vertebral fractures Low trauma fracture In past 5 years Risk Factors (table1)

More information

Fortisip Powder A high energy, high protein, nutritionally complete, powder supplement that can be mixed to desired energy concentration

Fortisip Powder A high energy, high protein, nutritionally complete, powder supplement that can be mixed to desired energy concentration A high energy, high protein, nutritionally complete, powder supplement that can be mixed to desired energy concentration Features Flexibility to prepare to various energy concentrations: 1kcal/ml, 1.5kcal/ml

More information

Multi-Vitamin PART OF YOUR ESSENTIALS PACK

Multi-Vitamin PART OF YOUR ESSENTIALS PACK Supplement Details Multi-Vitamin PART OF YOUR ESSENTIALS PACK A perfectly balanced all rounder. Our high quality multivitamin gives you a well balanced daily dose of a plethora of essential vitamins and

More information

Official Journal of the European Communities

Official Journal of the European Communities L 52/19 COMMISSION DIRECTIVE 2001/15/EC of 15 February 2001 on substances that may be added for specific nutritional purposes in foods for particular nutritional uses (Text with EEA relevance) THE COMMISSION

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Colecalciferol Meda 800 IU tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains colecalciferol (vitamin D 3 ) 800 IU

More information

Chapter 8 Malignant Disease and Immunosuppression

Chapter 8 Malignant Disease and Immunosuppression Chapter 8 page number 1 Chapter 8 Malignant Disease and Immunosuppression First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions)

More information

FM-IN-FC-01 Rev.1. PDF processed with CutePDF evaluation edition

FM-IN-FC-01 Rev.1. PDF processed with CutePDF evaluation edition ก 2553 ก ก ก (DIRECTIVE 2002/46/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCILof 10 June 2002 on the approximation of the laws of the Member States relating to food supplements) : ก ก ก ก : ก ก : 10

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 2001L0015 EN 11.04.2006 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION DIRECTIVE 2001/15/EC of 15 February

More information

concentrate intravenous solution and other strong potassium solutions

concentrate intravenous solution and other strong potassium solutions Policy for the use of potassium chloride concentrate intravenous solution and other strong potassium solutions CLINICAL GUIDELINES ID TAG Policy for the use of potassium chloride Title: concentrate intravenous

More information

PROFESSIONAL INFORMATION

PROFESSIONAL INFORMATION This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. SCHEDULING STATUS: Unscheduled: Complementary Medicine PROPRIETARY NAME AND DOSAGE FORM: BEROCCA

More information

Product Information:

Product Information: Product Information: Pro-Phree 1 of 5 Nutrition support of infants and toddlers who require extra calories, minerals, and vitamins and/or protein restriction. Use under medical supervision. Protein-free

More information

ESCA: Denosumab for the treatment of osteoporosis in postmenopausal women.

ESCA: Denosumab for the treatment of osteoporosis in postmenopausal women. ESCA: Denosumab for the treatment of osteoporosis in postmenopausal women. Specialist details Patient identifier Name Tel: This effective shared care agreement (ESCA) sets out details for the sharing of

More information

Use of Oral Nutritional Supplements in Primary Care Version 1 September 2017

Use of Oral Nutritional Supplements in Primary Care Version 1 September 2017 Use of Oral Nutritional Supplements in Primary Care Version 1 September 2017 VERSION CONTROL Version Date Amendments made Version 1 Sept 2017 New document. AG. Contents Page 2. Introduction 2. Malnutrition

More information

PROFESSIONAL INFORMATION

PROFESSIONAL INFORMATION This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. SCHEDULING STATUS: Unscheduled (Complementary medicine) PROPRIETARY NAME AND DOSAGE FORM: BEROCCA

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Calcium Sandoz 500 mg, effervescent tablets Calcium Sandoz 1000 mg, effervescent tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

Area Drug and Therapeutics Committee Prescribing Supplement No 47 July 2011

Area Drug and Therapeutics Committee Prescribing Supplement No 47 July 2011 Area Drug and Therapeutics Committee Prescribing Supplement No 47 In this issue Drugs reviewed by in May / June 2011 ADTC UPDATES ON DRUGS REVIEWED BY THE SMC The following new drugs have been reviewed

More information

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults Co-ordinators: Medicines Information Pharmacist Consultation Group: See relevant page in guidance Approver: Medicine Guidelines

More information

Product Information: Phenex -1

Product Information: Phenex -1 Product Information: Phenex -1 1 of 5 For nutrition support of infants and toddlers with phenylketonuria (PKU). Phenylalanine-free Use under medical supervision. Phenylalanine-free to allow greater intake

More information

Denosumab for the treatment of osteoporosis in postmenopausal women at increased risk of fractures

Denosumab for the treatment of osteoporosis in postmenopausal women at increased risk of fractures APper apc15-0avgfh7 Shared Care Guideline Denosumab for the treatment of osteoporosis in postmenopausal women at increased risk of fractures For the latest information on interactions and adverse effects,

More information

Package leaflet: Information for user

Package leaflet: Information for user Package leaflet: Information for user SANOFI (logo) Pharmaton Vitality Capsules Read all of this leaflet carefully before you start taking Pharmaton Vitality Capsules because it contains important information

More information

Product Information: Nepro with Carb Steady

Product Information: Nepro with Carb Steady Product Information: Nepro with Carb Steady 1 of 5 NEPRO WITH CARBSTEADY is therapeutic nutrition specifically designed to help meet the nutritional needs of patients on dialysis (Stage 5 chronic kidney

More information

Product Information: Tyrex -1

Product Information: Tyrex -1 Product Information: Tyrex -1 1 of 5 Nutrition support of infants and toddlers with tyrosinemia types I, II or III. Phenylalanine- and tyrosine-free. Use under medical supervision. Phenylalanine- and tyrosine-free

More information

Formulary and Prescribing Guidelines

Formulary and Prescribing Guidelines Formulary and Prescribing Guidelines SECTION 3: TREATMENT OF BIPOLAR AFFECTIVE DISORDER This section provides information regarding the pharmacological management of Bipolar affective disorder in secondary

More information

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults Co-ordinators: Sarah Gethings Medicine Information Pharmacist Consultation Group: See Page 4 Approver: Medicine Guidelines and

More information

Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol

Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol This is an official Northern Trust policy and should not be edited in any way Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Reference Number: NHSCT/12/553 Target

More information

Product Information: Propimex -1

Product Information: Propimex -1 Product Information: Propimex -1 1 of 5 Nutrition support of infants and toddlers with propionic or methylmalonic acidemia. Methionine- and valine-free; low in isoleucine and threonine. Use under medical

More information

ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharma UK Ltd

ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharma UK Ltd Resubmission ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharma UK Ltd 06 May 2011 The Scottish Medicines Consortium (SMC) has completed its assessment

More information

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care Berkshire West Integrated Care System Representing Berkshire West Clinical Commisioning Group Royal Berkshire NHS Foundation Trust Berkshire Healthcare NHS Foundation Trust Berkshire West Primary Care

More information

Product Information: Ketonex -1

Product Information: Ketonex -1 Product Information: 1 of 5 Nutrition support of infants and toddlers with maple syrup urine disease (MSUD). Isoleucine-, leucine- and valine-free. Use under medical supervision. Branched-chain amino acid-free

More information

Pathway from Fracture or Risk Factor to Treatment

Pathway from Fracture or Risk Factor to Treatment Appendix 6A - Guidance on Diagnosis and Management of Osteoporosis Pathway from Fracture or Risk Factor to Treatment Fragility Fracture = fracture sustained from a low energy fall from standing height

More information

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Nutrition and Dietetic Service Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Authors Hilary Mathieson, Renal Dietitian Paul McKeveney, Consultant Nephrologist

More information

S H A R E D C A R E G U I D E L I N E Drug: Denosumab 60mg injection Indication: treatment of osteoporosis in postmenopausal women

S H A R E D C A R E G U I D E L I N E Drug: Denosumab 60mg injection Indication: treatment of osteoporosis in postmenopausal women S H A R E D C A R E G U I D E L I N E Drug: Denosumab 60mg injection Indication: treatment of osteoporosis in postmenopausal women Introduction Indication: Denosumab (Prolia ) is recommended in NICE TA204

More information

Flavour: Red fruits, peach and passion fruit, orange, lime and grapefruit Package size: 1.7g Pharmaceutical form: Powder

Flavour: Red fruits, peach and passion fruit, orange, lime and grapefruit Package size: 1.7g Pharmaceutical form: Powder Flavour: Red fruits, peach and passion fruit, orange, lime and grapefruit Package size: 1.7g Pharmaceutical form: Powder Isotonic sports drink with added vitamins Energy Mineral is a multipurpose isotonic

More information

Denosumab (Prolia 60 mg) Effective Shared Care Agreement For the treatment of Osteoporosis. Date: Date:

Denosumab (Prolia 60 mg) Effective Shared Care Agreement For the treatment of Osteoporosis. Date: Date: Denosumab (Prolia 60 mg) Effective Shared Care Agreement For the treatment of Osteoporosis Section 1: Shared care arrangements and responsibilities Section 1.1 Agreement for transfer of prescribing to

More information

Package leaflet: Information for the user. Ibandroninezuur STADA 3 mg/3 ml, oplossing voor injectie. Ibandronic acid

Package leaflet: Information for the user. Ibandroninezuur STADA 3 mg/3 ml, oplossing voor injectie. Ibandronic acid Package leaflet: Information for the user Ibandroninezuur STADA 3 mg/3 ml, oplossing voor injectie Ibandronic acid Read all of this leaflet carefully before you start using this medicine because it contains

More information

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Name of Guideline / Policy/ Procedure MANAGEMENT OF ACUTE PAEDIATRIC ASTHMA Purpose of Procedure/

More information

Health Products Regulatory Authority IPAR. Public Assessment Report. Scientific discussion

Health Products Regulatory Authority IPAR. Public Assessment Report. Scientific discussion IPAR Public Assessment Report Scientific discussion Magnaspartate 243mg Powder for Oral Solution MAGNESIUM ASPARTATE DIHYDRATE IE/H/436/001/DC Date: 3 rd November 2014 This module reflects the scientific

More information

Kidney damage with normal or increased GFR Kidney damage with mild reduction in GFR

Kidney damage with normal or increased GFR Kidney damage with mild reduction in GFR CHRONIC KIDNEY DISEASE Contents Stages of Chronic Kidney Disease Dosing adjustments Hyperphosphataemia management Secondary hyperparathyroidism Anaemias Hyperkalaemia Acidosis Hypertension STAGES OF CHRONIC

More information

Guideline scope Neonatal parenteral nutrition

Guideline scope Neonatal parenteral nutrition NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Neonatal parenteral nutrition The Department of Health in England has asked NICE to develop a new guideline on parenteral nutrition in

More information

Product Information: Perative

Product Information: Perative Product Information: Perative 1 of 5 PERATIVE is designed for metabolically stressed patients who can benefit from an enteral formula supplemented with arginine. For tube feeding. For supplemental or sole-source

More information

Guidance for the administration of Denosumab (Prolia ) in Primary Care GENERAL INFORMATION should be recommended

Guidance for the administration of Denosumab (Prolia ) in Primary Care GENERAL INFORMATION should be recommended Guidance for the administration of Denosumab (Prolia ) in Primary Care GENERAL INFORMATION Denosumab is suitable for patients with established osteoporosis for both primary and secondary fracture prevention

More information

Safe and effective prescribing of nutrition: the impact of dietitian prescribing rights in New Zealand

Safe and effective prescribing of nutrition: the impact of dietitian prescribing rights in New Zealand Safe and effective prescribing of nutrition: the impact of dietitian prescribing rights in New Zealand Tory Crowder, Clinical Dietitian Christchurch Hospital, Canterbury District Health Board THANKYOU

More information

SUMMARY OF PRODUCT CHARACTERISTICS. One chewable tablet contains 1250 mg calcium carbonate (equivalent to 500 mg calcium).

SUMMARY OF PRODUCT CHARACTERISTICS. One chewable tablet contains 1250 mg calcium carbonate (equivalent to 500 mg calcium). SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT [XXX] 500 mg chewable tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One chewable tablet contains 1250 mg calcium carbonate (equivalent

More information

PROFESSIONAL INFORMATION

PROFESSIONAL INFORMATION This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. SCHEDULING STATUS: Unscheduled: Complementary Medicine PROPRIETARY NAME AND DOSAGE FORM: SUPRADYN

More information

Ingredient & Nutritional Information for Total Diet Replacement products

Ingredient & Nutritional Information for Total Diet Replacement products SHAKES Banana Chocolate Strawberry Vanilla SOUP Chicken & Mushroom PORRIDGE Original Flavour BARS Lemon Flavoured Yoghurt bar Peanut Crunch bar Shake Banana Flavour Energy kj 1516 607 kcal 360 144 Fat

More information

D.K.M COLLEGE FOR WOMEN (AUTONOMOUS) VELLORE-1 DEPARTMENT OF FOODS AND NUTRITION ESSENTIAL OF MICRO NUTRIENTS

D.K.M COLLEGE FOR WOMEN (AUTONOMOUS) VELLORE-1 DEPARTMENT OF FOODS AND NUTRITION ESSENTIAL OF MICRO NUTRIENTS D.K.M COLLEGE FOR WOMEN (AUTONOMOUS) VELLORE-1 DEPARTMENT OF FOODS AND NUTRITION ESSENTIAL OF MICRO NUTRIENTS Class: II M.Sc Subject Code: 15CPFN3A Unit - I (6 Marks Questions) 1. Write a note on performed

More information

Product Compendium Complete product list, guidance and support resources

Product Compendium Complete product list, guidance and support resources Product Compendium - 2018 Complete product list, guidance and support resources Contents Order Information & 5 Our purpose is to create better choices in medical nutrition and we aim to transform the market

More information

ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharmaceuticals

ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharmaceuticals ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharmaceuticals 17 December 2010 The Scottish Medicines Consortium (SMC) has completed its assessment

More information

GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE

GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if

More information

North Central London Joint Formulary Committee

North Central London Joint Formulary Committee North Central London Joint Formulary Committee Calcium + vitamin D supplementation for the prevention of osteoporotic fragility fractures Disclaimer This guideline is registered at North Central London

More information

DENOSUMAB SHARED CARE GUIDLINES

DENOSUMAB SHARED CARE GUIDLINES DENOSUMAB LICENSING Denosumab (PROLIA ) is licensed for the treatment of osteoporosis in postmenopausal women at increased risk of fractures and for bone loss associated with hormone ablation in men with

More information

Re: Important changes to Fortisip Powder

Re: Important changes to Fortisip Powder 18 June 2014 Dear valued customer Nutricia Ltd 37 Banks Road, Mount Wellington Auckland, New Zealand PO Box 62 523 Greenlane, Auckland 1546 Tel: 0800 688 747 Re: Important changes to Fortisip Powder Nutricia

More information

Product Nutrition Information

Product Nutrition Information Product Nutrition Information for OTE Sports Nutrition Products OTE ph Neutral Energy Drink Maltodextrin (purified and produced by the partial hydrolysis of a special starch), Fructose, Electrolytes (Sodium

More information

Barts Health NHS Trust and local GPs Shared Care Guidelines. DENOSUMAB (Prolia) Post menopausal osteoporosis

Barts Health NHS Trust and local GPs Shared Care Guidelines. DENOSUMAB (Prolia) Post menopausal osteoporosis Barts Health NHS Trust and local GPs Shared Care Guidelines Indication: DENOSUMAB (Prolia) Post menopausal osteoporosis DOCUMENT TO BE SCANNED INTO ELECTRONIC RECORDS AS AND FILED IN NOTES Patient Name

More information

Product Information: Perative

Product Information: Perative Product Information: Perative 1 of 5 PERATIVE is designed for metabolically stressed patients who can benefit from an enteral formula supplemented with arginine. For tube feeding. For supplemental or sole-source

More information

NHS Dumfries & Galloway Ferrous Salt Review Protocol November 09

NHS Dumfries & Galloway Ferrous Salt Review Protocol November 09 Title of Project: NHS Dumfries & Galloway Ferrous Salt Review Protocol November 09 1 Reason for the review Choice of iron preparation is based on cost and incidence of side effects (BNF). There is little

More information

DEKAs in Cystic Fibrosis

DEKAs in Cystic Fibrosis DEKAs in Cystic Fibrosis All-in-one Multivitamin & Mineral Dietary Supplement with Enhanced Absorption Roberto Jongejan, MD, PhD Gus Papas, MD, MPH Vitamin Malabsorption in Cystic Fibrosis In cystic fibrosis,

More information

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured. Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.

More information

Product Category: Pulmocare

Product Category: Pulmocare Product Category: Pulmocare Pulmocare Updated 4/8/2014 Product Information: Pulmocare 1 of 5 PULMOCARE is designed for people with chronic obstructive pulmonary disease (COPD), cystic fibrosis, or respiratory

More information

Summary of Product Characteristics

Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Desunin 4000 IU Tablets Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains colecalciferol (vitamin D 3 ) 4000 IU (equivalent

More information

Babies 1500g. Caffeine citrate. Sodium Acid Phosphate (1mmol/ml) Ferrous Fumarate (Galfer 140mg/5ml) Infloran. Abidec BMF

Babies 1500g. Caffeine citrate. Sodium Acid Phosphate (1mmol/ml) Ferrous Fumarate (Galfer 140mg/5ml) Infloran. Abidec BMF Babies 1500g Infloran Caffeine citrate BMF Sodium Acid Phosphate (1mmol/ml) Abidec Ferrous Fumarate (Galfer 140mg/5ml) Dose Half capsule BD 10mg/kg once daily (write as caffeine citrate) 2% BMF each feed

More information

Product Compendium /19. Complete product list, guidance and support resources

Product Compendium /19. Complete product list, guidance and support resources Product Compendium - 2018/19 Complete product list, guidance and support resources Our purpose is to give patients the best experience possible of medical nutrition whilst delivering the most innovative

More information

Guideline for the Diagnosis and Management of Vitamin D Deficiency

Guideline for the Diagnosis and Management of Vitamin D Deficiency Colchester Hospital University NHS Foundation Trust Guideline for the Diagnosis and Management of Vitamin D Deficiency As the symptoms and treatment doses can be different for adults and children, this

More information

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice Guideline for the investigation and management of osteoporosis for hospitals and General Practice Background Low bone density is an important risk factor for fracture. The aim of assessing bone density

More information

Product Category: Promote

Product Category: Promote Promote Product Category: Promote Promote Promote with Fiber Updated 5/23/2018 Promote Complete, balanced high protein nutrition Product Information: Promote 1 of 4 Promote Complete, balanced high protein

More information

Vitamin D deficiency: Altavita D3 - A range designed for compliance

Vitamin D deficiency: Altavita D3 - A range designed for compliance Vitamin D deficiency: Altavita D3 - A range designed for compliance Patient information Licensed for prevention and treatment of vitamin D deficiency Abbreviated prescribing information can be found on

More information

Product Category: Promote

Product Category: Promote Product Category: Promote Promote Promote with Fiber Updated 4/28/2016 Very-High-Protein Nutrition Product Information: Promote 1 of 5 Very-High-Protein Nutrition PROMOTE is a complete, balanced, very-high-protein

More information

Package leaflet: Information for the user. Calcichew-D 3 Melon 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )

Package leaflet: Information for the user. Calcichew-D 3 Melon 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 ) Package leaflet: Information for the user Calcichew-D 3 Melon 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 ) For medicinal products available on prescription only: Read all of this

More information

Product Information: EleCare (for Infants)

Product Information: EleCare (for Infants) 1 of 5 Product Information: 2 of 5 A 20 Cal/fl oz, nutritionally complete amino acid-based formula for infants who cannot tolerate intact or hydrolyzed protein. EleCare is indicated for the dietary management

More information

CAUTION: You must refer to the intranet for the most recent version of this procedural document.

CAUTION: You must refer to the intranet for the most recent version of this procedural document. Procedure for the use of Intravenous Iron Dextran (CosmoFer ) Sharepoint Location Sharepoint Index Directory Clinical Policies and Guidelines General Policies and Guidelines/ Haematology And blood transfusion

More information

SHARED CARE GUIDELINE

SHARED CARE GUIDELINE SHARED CARE GUIDELINE Title: Lithium Treatment in Adults aged 18-65 years Scope: Pennine Care NHS Foundation Trust NHS Bury NHS Oldham NHS Heywood, Middleton and Rochdale NHS Stockport NHS Tameside & Glossop

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3) PACKAGE LEAFLET: INFORMATION FOR THE USER 600 mg / 1,000 IU orodispersible tablets Calcium/cholecalciferol (Vitamin D3) Read all of this leaflet carefully before you start taking this medicine

More information